Results 201 to 210 of about 95,577 (390)

Gender Is the Main Predictor of Wearing‐Off and Dyskinesia in Levodopa‐Naïve Patients with Parkinson's Disease

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Evidence suggests that female gender represents a risk factor for the development of motor/nonmotor fluctuations and dyskinesia in Parkinson's disease (PD). So far, no prospective study has analyzed this aspect in relation to the introduction of levodopa treatment.
Maria Teresa Pellecchia   +41 more
wiley   +1 more source

Determinants of gait in the elderly parkinsonian on maintenance levodopa/carbidopa therapy. [PDF]

open access: green, 1990
SG Bowes   +8 more
openalex   +1 more source

Assessment of Safety and Efficacy of Safinamide as a Levodopa Adjunct in Patients With Parkinson Disease and Motor Fluctuations: A Randomized Clinical Trial

open access: yesJAMA Neurology, 2017
A. Schapira   +9 more
semanticscholar   +1 more source

Management of Anxiety in Parkinson's Disease

open access: yesMovement Disorders Clinical Practice, EarlyView.
ABSTRACT Background Anxiety is a common, distressing, hard‐to‐diagnose and hard‐to‐treat symptom in Parkinson's disease. No formal guidelines exist to assist management. Objective We provide a pragmatic guide to detecting and managing anxiety in Parkinson's disease.
Alex J. Berry   +4 more
wiley   +1 more source

The influence of protein containing meals on the pharmacokinetics of levodopa in healthy volunteers. [PDF]

open access: green, 1991
DR Robertson   +5 more
openalex   +1 more source

Stroke Mimicking Thalamotomy in Primary Familial Brain Calcification

open access: yes
Movement Disorders Clinical Practice, EarlyView.
Jaakko Kungshamn   +4 more
wiley   +1 more source

The Impact of Deep Brain Stimulation of the Subthalamic Nucleus on Sleep–Wake Function and Circadian Rhythms in Patients with Parkinson's Disease

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Deep brain stimulation (DBS) of the subthalamic nucleus (STN) is a well‐established therapy in advanced Parkinson's disease (PD) improving motor and non‐motor signs including sleep. The mechanisms of sleep improvement are insufficiently understood.
Julia Steinhardt   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy